Purchasers of AstraZeneca LP’s heartburn medication Nexium were not entitled to a new trial to their challenge of “reverse payment” agreements between AstraZeneca and Ranbaxy Pharmaceuticals that allegedly blocked the entry of a generic version of the drug, the U.S. Court of Appeals in Boston has decided. The plaintiffs’ argument that the trial court improperly…

The Patent Trial and Appeal Board properly found during inter partes review (IPR) that two claims of a patent directed to a mechanism for controlling the operation of a downhole drill string were invalid as anticipated by a prior art reference, the U.S. Court of Appeals for the Federal Circuit has decided. The court rejected…

1. History One of the most precious achievements that Europe inherited from England is the so-called Rule of Law, dating back from the days of James I who ruled the union of the Scottish and English crowns from 1603 until his death in 1625. The key parts of this model is that laws are made…

Actavis Laboratories UT, Inc. was unable to show that patents licensed to Endo Pharmaceuticals Inc. covering its testosterone gel product Fortesta® were invalid as obvious in light of prior art, according to the U.S. Court of Appeals for the Federal Circuit. Therefore, a district court ruling finding that the patents were not obvious was affirmed…

A district court did not err in dismissing an inventor’s claim that CBS Corporation, its CBS Interactive subsidiary, and “others under the control or direction of an independent contractor” hired by CBS to produce the television show “Big Brother” infringed two patents relating to methods and systems for obtaining real time responses from a broadcast…

In an inter partes review of a patent owned by Wi-Fi One, LLC (“Wi-Fi”), the Patent Trial and Appeal Board’s decision to deny Wi-Fi’s request to conduct discovery into whether Broadcom Corporation’ petition was time-barred under Section 315(b) of the Patent Act was not reviewable, the U.S. Court of Appeals for the Federal Circuit has…

A federal district court did not err in finding that a “cow monitoring system” developed by Netherlands-based Agis Automatisering did not infringe the “rumination” and “estrus” patents held by VocalTag Ltd. and SCR Engineering Ltd., respectively, the U.S. Court of Appeals for the Federal Circuit has ruled. The district court’s grant of summary judgment to…

The federal district court in Hartford, Connecticut, erred in denying judgment as a matter of law in an action in which a manufacturer of thermal flexographic processors alleged that a former partner misappropriated trade secrets engaged in an anticompetitive conspiracy that damaged the manufacturer’s business and hurt customers. The U.S. Court of Appeals in New…

The asserted claims of a DuPont patent disclosing a process for preparing flexographic printing plates were invalid as obvious over prior art and therefore could not support infringement contentions against DuPont’s competitor, MacDermid Printing Solutions, the U.S. Court of Appeals for the Federal Circuit has held. In addition, MacDermid’s Digital CST printing plates did not…

The Patent Trial and Appeal Board did not err in affirming a patent examiner’s rejection of three claims of an IPCom patent on a system for allowing access rights to cell phone channels, the U.S. Court of Appeals for the Federal Circuit has ruled. Because all three claims were anticipated by the GSM 04.60 Specifications,…